Skip to content
healthcare.dev

DESVENLAFAXINE

NDC 68071-5332, DESVENLAFAXINE, tablet, extended release, from NuCare Pharmaceuticals, Inc..

Product NDC
68071-5332
Status
Listed
Labeler
NuCare Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204028
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68071-5332 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DESVENLAFAXINE SUCCINATE50 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
68071-5332-36807153320330 TABLET, EXTENDED RELEASE in 1 PACKAGE (68071-5332-3)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5d43bde3-f052-51cb-e063-6294a90a6116

Use it

Look up 68071-5332 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68071-5332 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68071-5332. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.